AU
UK
CA
NZ
IND
US
Key HighlightsADVB stock down 16.21% to $4.55 following March 2025 IPO downsized to $6.56M from originally planned $150M+ offeringCompany's microfluidic platform detects circulating tumor cells (CTCs) for precision oncology applications with limited commercialization to dateChi-Mei Medical Center feasibility study of A+PerfusC platform underway with …
Key HighlightsWellchange Holdings (WCT) shares fell sharply 14.4% to $3.60 in today's trading session, marking one of the largest single-day declines among U.S.-listed equities.The significant decline comes amid the sharp decline likely reflects concerns about competitive pressures in china's digital health market and questions …
Why is RDNT stock falling today? The decline appears to be driven by a combination of company-specific developments and broader macroeconomic headwinds. Healthcare reimbursement pressures affecting imaging center profitability. Concerns about utilization rates and pricing power. For investors tracking this name, understanding the catalysts …
Shares of Neogen Corporation (NASDAQ: NEOG) experienced a notable pullback on March 7, 2026, with the stock price dropping 9.3% to close at $9.70. The move caught the attention of both retail and institutional investors, as the company joined a broader wave of selling …
Key HighlightsThe notable pullback comes amid clinical trial challenges or slow enrollment.Trading volume surged to 47.12K shares, with a relative volume of 1.75, indicating heightened institutional and retail interest in the stock.The company's market capitalization now stands at $19.55M, positioning it within the Biotechnology …
Key HighlightsThe notable pullback comes amid the decline may reflect concerns about clinical development progress, funding challenges, or competitive developments.Trading volume surged to 265.63K shares, with a relative volume of 0.66, indicating heightened institutional and retail interest in the stock.The company's market capitalization now …
Key HighlightsThe notable pullback comes amid slow adoption of vagus nerve stimulation therapy for migraines and other conditions.Trading volume surged to 47.17K shares, with a relative volume of 0.82, indicating heightened institutional and retail interest in the stock.The company's market capitalization now stands at …
Highlights
Highlights
Bausch Health Cos Inc (NYSE:BHC) released its Q4earnings, reporting USD 1.08 per share, below the consensus estimate of USD 1.22 by USD 0.14, according to Zacks. The company recorded a net margin of 3.61%, whilereturn on equityshowed a striking negative figure of ‑9,620.34%, highlighting …
Please wait processing your request...